Guerbet SA
PAR:GBT

Watchlist Manager
Guerbet SA Logo
Guerbet SA
PAR:GBT
Watchlist
Price: 9.46 EUR 1.5%
Market Cap: €119.6m

Guerbet SA
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Guerbet SA
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Guerbet SA
PAR:GBT
Research & Development
-€9.4m
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Crossject SA
PAR:ALCJ
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Affluent Medical SAS
PAR:AFME
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Guerbet SA
Glance View

Market Cap
119.6m EUR
Industry
Health Care

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,730 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

GBT Intrinsic Value
40.79 EUR
Undervaluation 77%
Intrinsic Value
Price €9.46

See Also

What is Guerbet SA's Research & Development?
Research & Development
-9.4m EUR

Based on the financial report for Dec 31, 2025, Guerbet SA's Research & Development amounts to -9.4m EUR.

What is Guerbet SA's Research & Development growth rate?
Research & Development CAGR 5Y
14%

Over the last year, the Research & Development growth was 27%. The average annual Research & Development growth rates for Guerbet SA have been 2% over the past three years , 14% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett